TEMPLATE:INFOBOX DRUG TESTCASES11

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=blank
Data page
	Template:Infobox drug/testcases11 (data page)

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dflt
Data page
	Template:Infobox drug/testcases11 (data page)

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dflt
Data page
	Template:Infobox drug/testcases11 (data page)

This is the template test cases page for the sandbox of Template:Infobox drug. Purge this page to update the examples.
If there are many examples of a complicated template, later ones may break due to limits in MediaWiki; see the HTML comment " NewPP limit report" in the rendered page.
You can also use Special:ExpandTemplates to examine the results of template uses.
You can test how this page looks in the different skins and parsers with these links:

Merge Template:Infobox neurohormone( talk links history) into Template:Infobox drug( talk links history) (2017)
Add gene therapy section (2018)

This testcase page uses {{ Infobox drug/sandbox}}. Diff: compare (pages: Template:Infobox drug, Template:Infobox drug/sandbox).

Testing Gene therapy

v t e Infobox drug development (Drugbox - talk central, overview, sandboxes, testcases) WT:PHARM
`/sandbox:` {{ Drugbox}} · e {{ title}} · e · src {{ licence}} · e · src {{ legal}} · e · src {{ pregcat}} · e · src {{ molarmass}} · e · src {{ mab source}} · e · src {{ localINNvar}} · e · src {{ maint cat}} · e · src {{ fmtATC}} · e · src /format · Infobox drug /sandbox ( · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit) FDA-2023 {{ Infobox drug/doc/FDA-2023}} · /testcases-FDA -- 2023 · /sandbox2 parameters Full parameter list ( ) · Type-conditional sections TPU cats: Category:Infobox drug tracking categories (32): Category:Pages using infobox drug with unknown parameters (13) · Parameter usage report cat: IBdrug templates · cat:Templates used in IBdrug testcases (m view): Template:Infobox drug/testcases -- General /testcases2 -- titles, licence, EMA /testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata /testcases4 -- chem formula, mab /testcases5 -- identifiers, second id's /testcases6 -- all up /testcases7images -- images /testcases8 -- type, titles /testcases9 -- order variants, container_only /testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect /testcases11 -- hormone, gene therapy (2018), has (data page) /testcases-FDA -- FDA 2023 /testcases-warning -- warning box(es) RC recent changes Chem+Drugbox templates · Drugbox transclusions Module:TemplatePar bot Settings.css · Settings/sandbox · {{ cascite}} chembox {{ Chem/dev/nav}} · {{ Chembox}} Infobox drug class /sandbox ( · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit) `Purge`

Diff: compare (pages: Template:Infobox drug, Template:Infobox drug/sandbox).

Has (data page): Template:Infobox drug/testcases11 (data page); This page has a data page to test this situation. (example: Caffeine has Caffeine (data page))

(data page)

Jan 2022: |data page=

This testpage has DP: Template:Infobox drug/testcases11 (data page)

(new) {{ Infobox drug/data page link}}

|data page= absent (dflt)

Side by side comparison

|data page=<blank>

Side by side comparison

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=blank
Data page
Template:Infobox drug/testcases11 (data page)

|data page=Water (data page)

Side by side comparison

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=water(DP)
Data page
Water (data page)

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=water(DP)
Data page
Water (data page)

|data page=[[Water (data page)]]

Side by side comparison

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=[water(DP)]
Data page
Water (data page)

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=[water(DP)]
Data page
Water (data page)

|data page=none

Side by side comparison

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=none

Infobox drug/testcases11
Clinical data
Pronunciation	test (DP) -dp=none

other older

|data page=
Water (data page)

Side by side comparison

Infobox drug/testcases11
Data page
Template:Infobox drug/testcases11 (data page)
^NY (what is this?) (verify)

Infobox drug/testcases11
Data page
Template:Infobox drug/testcases11 (data page)
^NY (what is this?) (verify)

|dat_ page=Foobar (xyz page)

Side by side comparison

Infobox drug/testcases11
Data page
Template:Infobox drug/testcases11 (data page)
^NY (what is this?) (verify)

Infobox drug/testcases11
Data page
Template:Infobox drug/testcases11 (data page)
^NY (what is this?) (verify)

Gene therapy

Pilot article is Voretigene neparvovec

Side by side comparison

Infobox drug/testcases11
Gene therapy
Target gene	RPE65
Vector	adenovirus serotype 2
Nucleic acid type	[not applicable here]
Editing method	[not applicable here]
Delivery method	[not applicable here]
Data page
Template:Infobox drug/testcases11 (data page)

Infobox drug/testcases11
Gene therapy
Target gene	RPE65
Vector	adenovirus serotype 2
Nucleic acid type	[not applicable here]
Editing method	[not applicable here]
Delivery method	[not applicable here]
Data page
Template:Infobox drug/testcases11 (data page)

2

Side by side comparison

Infobox drug/testcases11
Gene therapy
Target gene	RPE65
Vector	adenovirus serotype 2
Nucleic acid type	[not applicable here]
Editing method	[not applicable here]
Delivery method	[not applicable here]
Data page
Template:Infobox drug/testcases11 (data page)

Infobox drug/testcases11
Gene therapy
Target gene	RPE65
Vector	adenovirus serotype 2
Nucleic acid type	[not applicable here]
Editing method	[not applicable here]
Delivery method	[not applicable here]
Data page
Template:Infobox drug/testcases11 (data page)

Testcase 1

Testcase comparing the previous template (now deprecated)

nowiki

{| style="vertical-align:top" |- | colspan=2 | [[Oxytocin]] |- | {{tl|Infobox drug/sandbox}} | {{tl|Infobox neurohormone}} |- |{{Infobox drug/sandbox | type= | drug_name = Oxytocin (hormone) | IUPAC_name = 1-({(4''R'',7''S'',10''S'',13''S'',16''S'',19''R'')-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1''S'')-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide | image = Oxytocin with labels.png | width = 250px  | source_tissues = [[posterior pituitary]] | target_tissues = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | biosynthesis = [[magnolysin]] | metabolism = [[oxytocinase]] | legal_US= blabla-test | class = clinicalclass  | bioavailability = | protein_bound = 30%  | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6  | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} |{{Infobox neurohormone  | name = Oxytocin (hormone) | alt =  | IUPACName = 1-({(4''R'',7''S'',10''S'',13''S'',16''S'',19''R'')-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1''S'')-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide | synonyms = | abbrev =  | image = Oxytocin with labels.png  | sources = [[posterior pituitary]] | targets = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | synth = [[magnolysin]] | breakdown = [[oxytocinase]]  | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6  | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N | footnotes = }} |}

test metabolism in two sections

Side by side comparison

M. with physiological data only
Physiological data
Source tissues	posterior pituitary
Target tissues	central nervous system
Receptors	oxytocin receptor
Agonists	carbetocin, demoxytocin, merotocin
Antagonists	atosiban, epelsiban, retosiban
Precursor	oxytocin-neurophysin 1
Biosynthesis	magnolysin
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
3D model ( JSmol)	Interactive image
SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1^Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N^Y
Data page
Template:Infobox drug/testcases11 (data page)

M. with physiological data only
Physiological data
Source tissues	posterior pituitary
Target tissues	central nervous system
Receptors	oxytocin receptor
Agonists	carbetocin, demoxytocin, merotocin
Antagonists	atosiban, epelsiban, retosiban
Precursor	oxytocin-neurophysin 1
Biosynthesis	magnolysin
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
3D model ( JSmol)	Interactive image
SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1^Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N^Y
Data page
Template:Infobox drug/testcases11 (data page)

Side by side comparison

M. with pharmacokinetic data only
Pharmacokinetic data
Bioavailability	xyz
Protein binding	30%
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
3D model ( JSmol)	Interactive image
SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1^Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N^Y
Data page
Template:Infobox drug/testcases11 (data page)

M. with pharmacokinetic data only
Pharmacokinetic data
Bioavailability	xyz
Protein binding	30%
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
3D model ( JSmol)	Interactive image
SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1^Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N^Y
Data page
Template:Infobox drug/testcases11 (data page)

Side by side comparison

M. with physio and pharmacokin data both
Physiological data
Source tissues	posterior pituitary
Target tissues	central nervous system
Receptors	oxytocin receptor
Agonists	carbetocin, demoxytocin, merotocin
Antagonists	atosiban, epelsiban, retosiban
Precursor	oxytocin-neurophysin 1
Biosynthesis	magnolysin
Metabolism	oxytocinase
Pharmacokinetic data
Bioavailability	xyz
Protein binding	30%
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
3D model ( JSmol)	Interactive image
SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1^Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N^Y
Data page
Template:Infobox drug/testcases11 (data page)

M. with physio and pharmacokin data both
Physiological data
Source tissues	posterior pituitary
Target tissues	central nervous system
Receptors	oxytocin receptor
Agonists	carbetocin, demoxytocin, merotocin
Antagonists	atosiban, epelsiban, retosiban
Precursor	oxytocin-neurophysin 1
Biosynthesis	magnolysin
Metabolism	oxytocinase
Pharmacokinetic data
Bioavailability	xyz
Protein binding	30%
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
3D model ( JSmol)	Interactive image
SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1^Y Key:XNOPRXBHLZRZKH-DSZYJQQASA-N^Y
Data page
Template:Infobox drug/testcases11 (data page)

Side by side comparison

M. with M. value only
Pharmacokinetic data
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
Data page
Template:Infobox drug/testcases11 (data page)

M. with M. value only
Pharmacokinetic data
Metabolism	oxytocinase
Identifiers
CAS Number	50-56-6^Y
Chemical and physical data
Formula	C₄₃H₆₆N₁₂O₁₂S₂
Molar mass	1007.19 g/mol g·mol⁻¹
Data page
Template:Infobox drug/testcases11 (data page)

text metabolism, and pronunciation

nowiki

{{tl|Infobox drug/sandbox}} {{testcase table | type= | drug_name = M. with physiological data only | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg  | source_tissues = [[posterior pituitary]] | target_tissues = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | biosynthesis = [[magnolysin]] | metabolism = [[oxytocinase]]  | bioavailability = | protein_bound =   | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6  | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} {{testcase table | type= | drug_name = M. with pharmacokinetic data only | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg  | metabolism = [[oxytocinase]]  | bioavailability = xyz | protein_bound = 30%  | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6  | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} {{testcase table | type= | drug_name = M. with physio and pharmacokin data both | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg  | source_tissues = [[posterior pituitary]] | target_tissues = [[central nervous system]] | receptors = [[oxytocin receptor]] | agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]] | antagonists = [[atosiban]], [[epelsiban]], [[retosiban]] | precursor = [[Neurophysin I|oxytocin-neurophysin 1]] | biosynthesis = [[magnolysin]] | metabolism = [[oxytocinase]]  | bioavailability = xyz | protein_bound = 30%  | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6  | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol | smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N }} {{testcase table | type= | drug_name = M. with M. value only | IUPAC_name = | pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}} | image = Aspirin-skeletal.svg  | source_tissues = | target_tissues = | receptors = | agonists = | antagonists = | precursor = | biosynthesis = | metabolism = [[oxytocinase]]  | bioavailability = | protein_bound =  | CAS_number_Ref = {{cascite|correct}} | CAS_number = 50-56-6  | C=43 | H=66 | N=12 | O=12 | S=2 | molecular_weight = 1007.19 g/mol }}

(data page)

other older

Gene therapy

Testcase 1

test metabolism in two sections

text metabolism, and pronunciation

(data page)

other older

Gene therapy

Testcase 1

test metabolism in two sections

text metabolism, and pronunciation

Videos

Websites

Encyclopedia

Facebook